Dr Jeff Smaill and Dr Adam Patterson
Scientists Dr Jeff Smaill and Dr Adam Patterson at the Auckland Cancer Society Research Centre collaborate on developing a prodrug that works by targeting hypoxic cells in a tumour and avoiding the oxygenated healthy cells.
